The information script substantially increased people’s knowledge about intestinal worms– respondents who were given the script scored 29-34 percentage points higher on a nine-question worm quiz. However, it had no impact on their ultimate purchase decision.
Liquidity appears to be an important component of demand. The cash payout significantly increased demand, especially at intermediate or high prices. On average, every additional 100 Ksh in cash payout increased the probability of purchase by 22 percentage points. Targeting women also affects demand. Women appear to be more likely to invest in children’s health products, by redeeming the coupon. When a male was offered the coupon, the household was 5-9 percentage points less likely to buy shoes.
While there seem to be important liquidity constraints and gender impacts, by far the most important predictor of shoe purchase is price: about 78 percent of the variation in health product purchases may be explained through variation in price alone. While 93 percent of households bought when the price was 5 Ksh, only 42 percent bought at 65 Ksh. As the market price is around 85 Ksh, this suggests that the majority of people value shoes at a price lower than the market price.
The researchers find no evidence that a household's purchase increases the chance that their neighbor will also purchase preventative health products. Even though parents reported that they wanted the shoes more when they saw neighboring kids wearing them, the price remained the limiting barrier. In addition, people talked about the program so many neighbors knew the prices that others in the sample paid. While an individual might be seen as a “bad parent” if they didn’t redeem a low-priced coupon, they would not be seen as such if they didn’t buy shoes at the full price.
The researchers found similar results in the three smaller studies, suggesting that most of the basic experimental results are unlikely to be specific to the Kenyan context. For further details on the three smaller studies, see
Keeping the Doctor Away: Experimental Evidence on Investment in Preventive Health Products.